Summary
An open study was carried out in ten healthy, male volunteers in order to investigate the renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic. Subjects received a single dose of 1.0 g of cefpirome and then repeated doses of 1.0 g of cefpirome twice daily for five days. Urine was collected in several fractions during the study and the urine excretion, excretions of creatinine, N-acetyl-β-D-glucosaminidase, gamma glutamyltransferase, alanine aminopeptidase and lactate dehydrogenase were calculated in 12-hour fractions. Serum creatinine (using an enzymatic method), β2-microglobulin concentrations and creatinine clearance were also determined. Based on the findings of these renal enzymes, renal tolerance was good. This was also confirmed by creatinine clearance calculations and follow-up of serum β2-microglobulin levels. Cefpirome showed good renal tolerance without any signs of nephrotoxicity in this study with the methods used.
Zusammenfassung
Die Nierenverträglichkeit von Cefpirom (HR 810), einem neuen Cephalosporin-Antibiotikum, wurde in einer offenen Studie mit zehn gesunden männlichen Probanden geprüft. Die Probanden erhielten zuerst eine Einzeldosis von 1,0 g Cefpirom und danach 1,0 g Cefpirom zweimal täglich für fünf Tage. Harn wurde in mehreren Fraktionen während der Studie gesammelt, und die Urinausscheidung, Ausscheidungen von Kreatinin, N-azetyl-β-D-Glukosaminidase, Gamma-Glutamyltransferase, Alanin-Aminopeptidase und Laktatdehydrogenase wurden in 12-Stunden Fraktionen berechnet. Die Konzentrationen von Serum-Kreatinin (bestimmt mit einer enzymatischen Methode) und β2-Mikroglobulin sowie Kreatinin-Clearance wurden ebenso bestimmt. Die gute Nierenverträglichkeit wurde durch die Nierenenzyme, Kreatinin-Clearance-Bestimmungen und die β2-Mikroglobulin-Spiegel im Serum bestätigt. Cefpirom zeigte in dieser Studie mit den verwendeten Methoden eine gute renale Verträglichkeit ohne irgendwelche Hinweise auf Nephrotoxizität.
Similar content being viewed by others
Literature
Seibert, G., Klesel, N., Limbert, M., Schrinner, E., Seeger, K., Winkler, I., Lattrell, R., Blumbach, J., Dürckheimer, W., Fleischmann, K., Kirrstetter, R., Mencke, B., Ross, B. C., Scheunemann, K.-H., Schwab, W., Wieduwilt, M. HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneim.-Forsch./Drug Res. 33 (1983) 1084–1086.
Atkinson, R. M., Currie, J. P., Davis, B., Pratt, D. A. H., Sharpe, H. M., Tomich, E. G. Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol. Appl. Pharmacol. 8 (1966) 398–406.
Engle, J. E., Drago, J., Carlin, B., Schoolwerth, A. C. Letter; Reversible acute renal failure after cephalothin. Ann. Intern. Med. 83 (1975) 232–233.
Burton, J. R., Lichtenstein, N. S., Colvin, R. B., Hyslop, N. E. Acute renal failure during cephalothin therapy. J. Am. Med. Assoc. 229 (1974) 679–682.
Morin, J. P., Fresel, J., Fillastre, J. P., Vaillant, R. Aminoglycoside action on rat kidney lysosomes“in vitro” and“in vivo”. In: Nephrotoxicity: Interaction of drugs and membrane systems. Mitochondria — lysosomes: Masson, N. Y. 1978, p. 253.
Price, R. G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 23 (1982) 99–134.
Dance, N., Price, R. G., Cattell, W. R., Lansdell, J., Richards, B. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with renal disease. Clin. Chim. Acta 27 (1970) 87–92.
Luft, F. C., Patel, V., Yum, M. N., Patel, B., Kleit, S. A. Experimental aminoglycoside nephrotoxicity. J. Lab. Clin. Med. 86 (1975) 213–220.
Luft, F. C., Patel, V. Lysosomal acid hydrolases as urinary markers of aminoglycoside nephrotoxicity in the rat. In: Nephrotoxicity: interaction of drugs and membrane systems, Masson, N. Y. 1978, p. 127.
Kolb, R., Markhof, C. M., Zekert, F. Verhalten von Harnenzymen nach Vitamin A, Gentamycin und Klemmung der Nierenarterien. Wien. Klin. Wochenschr. 88 (1976) 463–467.
Mondorf, A. W. Investigations on the potential nephrotoxicity of cefazedone and gentamicin and of their combination, in comparison with the combination of cefazolin and cephalothin with gentamicin. Arzneim.-Forsch./Drug. Res. 29 (1979) 449–452.
Beck, H. J., Nierhoff, N., Sack, K. Experimental studies in animals on the nephrotoxicity of some new cephalosporin antibiotics: cefamandole, EMD 29 645, and 29 946. Arzneimittel-Forschung 30 (1980) 660–666
Evrin, P. E., Wibell, L. The serum levels and urinary excretion of β2-microglobulin in apparently healthy subjects. Scand. J. Clin. Lab. Invest. 29 (1972) 69–74.
Wibell, L., Evrin, P. E., Berggard, I. Serum β2-microglobulin in renal disease. Nephron 10 (1973) 320–331.
Kult, J., Lämmlein, Ch., Röckel, A., Heidland, A. β2-Mikroglobulin im Serum — ein Parameter des Glomerulumfiltrates. Dtsch. Med. Wochenschr. 99 (1974) 1686–1688.
Berscheid, G., Grötsch, H., Hropot, M., Klaus, E., Mattenheimer, H. Enzymuria of the rat: the preparation of urine for enzyme analysis. J. Clin. Chem., Clin. Chim. Acta 15 (1967) 275–282.
Szasz, G. G-Glutamyltranspeptidase-Aktivität im Urin. J. Clin. Chem., Clin. Biochem. 8 (1970) 1–8.
Optimized standard method of the German Society for Clinical Chemistry. J. Clin. Chem., Clin. Biochem. 8 (1970) 658–660.
Optimized standard method of the German Society for Clinical Chemistry. J. Clin. Chem., Clin. Biochem. 10 (1972) 182–192.
Barza, M. The nephrotoxicity of cephalosporins: an over-view. J. Infect. Dis. 137 (1978) 60–73.
Tune, B. M., Fravert, D. Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin. Kidney Int. 18 (1980) 591.
Morin, J. P., Fillastre, J. P., Olier, B. Antibiotic nephrotoxicity. Chemioterapia 3 (1984) 33–40.
Sack, K., Marre, R., Schulz, E. Renal side-effects of beta-lactam antibiotics. Krankenhauspharmazie 6 (1985) 415–418.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verho, M., Maaß, L., Malerczyk, V. et al. Renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic. Infection 15, 215–219 (1987). https://doi.org/10.1007/BF01646054
Issue Date:
DOI: https://doi.org/10.1007/BF01646054